港股创新药概念股走强，药明康德涨超4%

Core Viewpoint - The Hong Kong innovative drug concept stocks have shown strong performance, with several companies experiencing significant gains in their stock prices [1] Group 1: Stock Performance - WuXi AppTec (药明合联) increased by 6% [1] - WuXi Biologics (药明生物) and 3SBio (三生制药) both rose by over 3% [1] - Other companies such as Innovent Biologics (信达生物), Genscript Biotech (巨子生物), and Hengrui Medicine (恒瑞医药) saw increases of over 2% [1]